Abstract：OBJECTIVE: To explore the roles of granulocyte colony-stimulating factor in the pathogenesis of moyamoya disease. METHODS: Serum G-CSF concentrations were measured using enzyme linked immunosorbent assay (ELISA) in 20 children with moyamoya disease and 20 healthy children. RESULTS: Serum G-CSF concentration (35.7±10.3 pg/mL) in children with moyamoya disease was significantly higher than that in healthy controls (23.5±3.8 pg/mL) (P<0.01). CONCLUSIONS: The elevated serum G-CSF concentration in children with moyamoya disease suggests that G-CSF may play an important role in the pathogenesis of moyamoya disease.［Chin J Contemp Pediatr, 2010, 12 (2):117-119］
MA Ming-Sheng,ZOU Li-Ping,DING Ying-Xue et al. Concentrations of granulocyte colony-stimulating factor in children with moyamoya disease[J]. CJCP, 2010, 12(2): 117-119.
［3］Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor［J］. Blood, 1991, 78(11):2791-2808.
［4］Xiao BG, Lu CZ, Link H.Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection［J］. Cell Mol Med, 2007, 11(6):1272-1290.
［5］高山.烟雾病诊断标准［J］.中国卒中杂志, 2008, 3(7):500-501.
［6］Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, et al. Levels of serum granulocyte colony-stimulating factor in patients with infections［J］. Blood, 1990, 76(10):1962-1964.
［7］Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay［J］. Blood, 1989, 73(1):117-122.
［8］Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis［J］. J Clin Invest, 2005, 115(8):2083-2098.
［9］Kleinschnitz C, Schroeter M, Jander S, Stoll G. Induction of granulocyte colony-stimulating factor mRNA by focal cerebral ischemia and cortical spreading depression［J］. Brain Res Mol Brain Res, 2004, 131(1-2):73-78.
［13］Sakamoto S, Kiura Y, Yamasaki F, Shibukawa M, Ohba S, Shrestha P, et al. Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease［J］. Neurosurg Rev, 2008, 31(1):77-81.
